col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Acta Naturae Ltd

12 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Acta Naturae 2026―Apr―21 Identifying microRNA expression alterations in erythrocytes, lymphocytes, and monocytes during severe COVID-19 A. A. Artamonov, Yu. V. Nikitin, A. A. Velmiskina, S. V. Mosenko, V. S. Shimansky, A. Yu. Asinovskaya, et al. (+5)
2 [GO] Acta Naturae 2025―Dec―23 The parameters of long-term humoral immunity induced by a single injection of the Sputnik Light vaccine among non-infected volunteers and those infected with SARS-CoV-2 F. M. Izhaeva, A. I. Tukhvatulin, A. S. Dzharullaeva, I. V. Dolzhikova, O. V. Zubkova, D. V. Shcheblyakov, et al. (+11)
3 [GO] Acta Naturae 2024―Aug―22 Ceramides As Potential New Predictors of the Severity of Acute Coronary Syndrome in Conjunction with SARS-CoV-2 Infection N. G. Lozhkina, O. I. Gushchina, N. V. Basov, E. V. Gaisler, A. D. Rogachev, Yu. S. Sotnikova, et al. (+2)
4 [GO] Acta Naturae 2024―Jan―19 <i>In Vitro</i> Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2 A. N. Narovlyansky, M. V. Filimonova, N. G. Tsyshkova, A. V. Pronin, T. V. Grebennikova, E. V. Karamov, et al. (+26)
5 [GO] Acta Naturae 2023―May―03 Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain Yana O. Romanenko, Marina V. Silkina, Alena S. Kartseva, Maksim A. Marin, Maria A. Shkuratova, Maria A. Makarova, et al. (+6)
6 [GO] Acta Naturae 2023―Jan―21 The Fallout of Catastrophic Technogenic Emissions of Toxic Gases Can Negatively Affect Covid-19 Clinical Course Giancarlo Succi, Witold Pedrycz, Anna P. Bogachuk, Alexander G. Tormasov, Alexey A. Belogurov, Aldo Spallone
7 [GO] Acta Naturae 2022―Oct―29 An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity Nikita N. Kostin, Tatiana V. Bobik, George A. Skryabin, Mariya A. Simonova, Vera D. Knorre, Victoria A. Abrikosova, et al. (+7)
8 [GO] Acta Naturae 2022―Jan―27 Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2 Elena S. Matyugina, Mikhail S. Novikov, Liubov I. Kozlovskaya, Victor P. Volok, Elena Y. Shustova, Aidar A. Ishmukhametov, et al. (+2)
9 [GO] Acta Naturae 2021―Nov―15 Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients Airat F. Khalirakhmanov, Kamilla F. Idrisova, Raushaniya F. Gajfullina, Sergey V. Zinchenko, Rustem I. Litvinov, Aydar Z. Sharafeev, et al. (+2)
10 [GO] Acta Naturae 2021―Nov―15 Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2 Aleksandra A. Nikonova, Eugene B. Faizuloev, Anastasia V. Gracheva, Igor Yu. Isakov, Vitaly V. Zverev
11 [GO] Acta Naturae 2021―Apr―21 COVID-19 in Russia: Clinical and Immunological Features of the First-Wave Patients Tatiana V. Bobik, N. N. Kostin, G. A. Scriabin, P. N. Tsabai, M. A. Simonova, Vera D. Knorre, et al. (+9)
12 [GO] Acta Naturae 2020―Oct―27 Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the middle east respiratory syndrome Inna V. Dolzhikova, D. M. Grousova, O. V. Zubkova, A. I. Tukhvatulin, A. V. Kovyrshina, N. L. Lubenets, et al. (+17)
 [1] 

12 Results       Page 1




[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.023 sec